Revenue (Quarterly) Chart

View Revenue (Quarterly) for PBIO.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Revenue (Quarterly) Chart
Start Trial

Historical Revenue (Quarterly) Data

View and export this data back to 1998. Start Trial.
Date Value
June 30, 2024 0.4218M
March 31, 2024 0.3493M
December 31, 2023 0.3124M
September 30, 2023 0.413M
June 30, 2023 0.5118M
March 31, 2023 0.7406M
December 31, 2022 0.6072M
September 30, 2022 0.144M
June 30, 2022 0.4981M
March 31, 2022 0.48M
December 31, 2021 0.3152M
September 30, 2021 0.5184M
June 30, 2021 0.6089M
March 31, 2021 0.5599M
December 31, 2020 0.1647M
September 30, 2020 0.5339M
June 30, 2020 0.2682M
March 31, 2020 0.2539M
December 31, 2019 0.2799M
September 30, 2019 0.5012M
June 30, 2019 0.5187M
March 31, 2019 0.5102M
December 31, 2018 0.6866M
September 30, 2018 0.5218M
June 30, 2018 0.6388M
Date Value
March 31, 2018 0.6108M
December 31, 2017 0.5027M
September 30, 2017 0.6461M
June 30, 2017 0.5404M
March 31, 2017 0.5514M
December 31, 2016 0.4197M
September 30, 2016 0.5353M
June 30, 2016 0.511M
March 31, 2016 0.5105M
December 31, 2015 0.3641M
September 30, 2015 0.5803M
June 30, 2015 0.4131M
March 31, 2015 0.4401M
December 31, 2014 0.2906M
September 30, 2014 0.3725M
June 30, 2014 0.3075M
March 31, 2014 0.4041M
December 31, 2013 0.3541M
September 30, 2013 0.4208M
June 30, 2013 0.3577M
March 31, 2013 0.3707M
December 31, 2012 0.216M
September 30, 2012 0.3916M
June 30, 2012 0.3249M
March 31, 2012 0.3057M

Revenues Definition

Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.

Read full definition.

Revenue (Quarterly) Range, Past 5 Years

View Revenue (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Revenue (Quarterly) Benchmarks

View Revenue (Quarterly) Benchmarks
Start Trial
Agilent Technologies, Inc. 1.878B
Bio-Rad Laboratories, Inc. 651.00M
Bruker Corp. 838.50M
Danaher Corp. 6.265B
Harvard Bioscience, Inc. 22.73M